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Abstract
The approximately 50 known chemokines are classified in distinct subfamilies;
CXC, CC, CX3C and C. Although the signaling of chemokines often is promiscu-
ous, signaling events between members of these distinct chemokine classes are hard-
ly observed. The only known exception so far is the murine CC chemokine CCL21,
which binds and activates the murine CXC chemokine receptor CXCR3. This
exception however has not been found in humans. Here we provide evidence that
human CCL21 is a functional ligand for endogenously expressed CXCR3 in human
adult microglia. In absence of CCR7 expression, CCL21 induced chemotaxis of
human microglia with efficiency similar to the CXCR3 ligands CXCL9 and
CXCL10. Since human CCL21 did not show any effects in CXCR3 transfected
HEK293 cells it is indicated that CXCR3 signaling depends on the cellular back-
ground in which the CXCR3 is expressed. 
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Introduction
In the peripheral immune system chemokines regulate migration of leukocytes
expressing specific chemokine receptors 9. Based on conserved cysteine residues
chemokines and their receptors are subdivided into four families: CXC-, CC-, C-
and CX3C-chemokines 27. Chemokine signaling can be promiscuous and a variety
of chemokines activate more than one chemokine receptor. This promiscuity, how-
ever, is only observed within chemokine families, signaling between members of dif-
ferent chemokine families is no common phenomenon 15,19. The only known excep-
tion so far concerns CCL21 that binds and activates mouse CXCR3 14,28,31. In the
periphery CCL21 and the related chemokine CCL19 (ELC) are known to be home-
ostatic chemokines that activate CCR7, whereas CXCR3 is activated by CXCL9,
CXCL10 and CXCL11 chemokines that belong to the inflammatory chemokines
15,19.
It is clear that chemokines and their receptors are also expressed in the central
nervous system (CNS). Here chemokines, at least partially, control the infiltration
of blood leukocytes into the brain and are involved in different brain pathologies
1,10,16. 
Recently, we have described the induction of CCL21 expression in ischemic
mouse neurons and the effects of CCL21 in microglia, suggesting the involvement
of CCL21 in the communication between damaged neurons and microglia 3,7,29.
Surprisingly, murine microglia responded to CCL21 stimulation in the absence of
CCR7 via the alternative receptor CXCR3 3,4,24, confirming results previously
obtained in a recombinant expression system 28. 
The validity of CCL21 as a neuronally derived activator of microglia in humans
was challenged since activity of human CCL21 (hCCL21) on human CXCR3
(hCXCR3) has not been found 14,31. However, none of these studies were conducted
in (CCR7 lacking) primary human cells. We therefore studied possible effects of
human CCL21 in primary adult microglia. 
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Experimental procedures
Cultured human primary microglia and HEK293
Human brain tissue was obtained by rapid autopsy. All patients or their next of kin
had given written consent for autopsy during life, and for use of their brain tissue
for research purposes. Microglial cell cultures were obtained as described previously
8. To induce proliferation of microglial cells recombinant human granulocyte-
macrophage colony stimulating factor (rhGM-CSF; stock solution 300 µg/ml;
Leucomax, Novartis, The Netherlands) was added (final concentration 25 ng/ml).
Microglial cells immunostained (> 90-98%) with anti Mac1 (CD11b), LeuM5
(CD11c), LeuM3 (CD14), KP1 (CD68) and FcγRI (CD64) whereas they were neg-
ative for GFAP. HEK293 cells were maintained in DMEM containing 10% fetal calf
serum with 0,01% penicillin and 0,01% streptomycin in a humidified atmosphere
(5% CO2) at 37°C. 
Cloning of CXCR3 and transfection of HEK293 cells
Full-length murine CXCR3 (mCXCR3) was obtained from total RNA extracted
from murine mixed glial cell cultures as described 2. Primers for the full length
sequence of mCXCR3 were designed based on the published sequence (accession
no. AF045146): forward primer: 5’-GCAAGTTCCCAACCACAAGT-3’; back-
ward primer: 5’-CGAGCTAGCCCAACT ACCAGGAGGA-3’. The PCR product
was cloned into pCRII.1 (Invitrogen), sequenced and subcloned into pCDNA3.1
for transfection experiments. Plasmids containing hCXCR3 were a kind gift of C.
Tensen and B. Moser 13. One µg of the plasmids was transfected with 6 µl FugeneR
(Roche Molecular Biochemicals) in HEK293 cells. Stably transfected cells were
selected with G418 500 µg/ml. Mock transfections were performed with pcDNA
3.1 containing the reversed CXCR3 sequence.
Immunocytochemistry
Cells were seeded on poly-L-lysine-coated glass cover-slides and fixed in 4%
paraformaldehyde for 30 min. After rinsing in PBS and pre-incubation in PBS con-
taining 0.3% Triton X-100 (PBS+) and 5% normal goat serum, slides were incubat-
ed in PBS+ with 2% normal goat serum and human CD11b (Mac-1, Chemicon) or
mouse anti hCXCR3 (R&D Systems) for 2 hours and visualized with a Cy3 labeled
goat anti mouse secondary antibody. Control experiments for all immunocyto-
chemical stainings were done by incubating cells with an isotype-matched primary
antibody against GFAP (Chemicon) or in the absence of primary antibodies. 
107
> H u m a n  m i c r o g l i a  r e s p o n d  t o  C C L 2 1 <
Reverse Transcripiton-Polymerase Chain Reaction (RT-PCR)
RNA preparation and reverse transcriptase were performed as described previously 2.
Two µl of cDNA was amplified in the PCR using the following two primer pairs for
CCR7: forward 5’- ACCAATGAAAAGCGTGCTG - 3’; backward 5’- CGCC-
GATGAAG-GCGTACAA -3’ (977 bp) and: forward 5’ – TGAGGTCACGGAC-
GATTACA – 3’; backward 5’ – CATGCCACTGAAG AAGCTCA – 3’ (355 bp)
with an annealing temperature of 56°C and 35 cycles. As a control for cDNA qual-
ity, experiments with primers for the housekeeping gene GAPDH: forward 5’-
CATCCTGCACCACCAACTGCTTAG -3’; backward 5’- GCCTGCTTCA
CCACCTTCTTGATG -3’ were done in parallel with an annealing temperature of
60°C and 28 cycles.  
In situ hybridization
The cellular distribution of CXCR3 mRNA was investigated by in situ hybridiza-
tion experiments as described earlier 2 using CXCR3 digoxigenin-conjugated sense
and antisense probes. 
Chemotaxis assays
Migration of microglia and CXCR3 transfected HEK293 cells in response to
CXCL9, CXCL10, CCL19, CCL21 and CX3CL1 (R&D systems) was determined
as described earlier 2. For experiments in the presence of CXCL10, microglia were
first pretreated with 10 nM CXCL10 for 10 min at 37°C and thereafter the chemo-
taxis was measured in the presence of 10 nM CXCL10 in the lower and the upper
chamber of the microchamber. 1,5·104 microglial cells or 3·104 transfected HEK293
cells were applied per well (50 µl) in the upper chamber. Migrated cells were count-
ed and data are presented as percentages of control-migration. 
Statistical analysis
Statistical analysis and comparison of the different groups was done with the Tukey
ANOVA test for multiple comparison (SPSS Inc., Chicago, USA) with a signifi-
cance level of 0.05. 
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Results
Expression of CXCR3 but not CCR7 in human microglia and 
CXCR3 transfected HEK293 cells
The presence of CXCR3 in stably transfected HEK293 cells and microglia was con-
firmed by immunocytochemistry (fig. 4-1) and in situ hybridization (fig. 4-2).
Stably transfected HEK293 cells showed intense immunostaining for hCXCR3 (fig.
4-1A) and mCXCR3 (fig. 4-1B). Non-transfected HEK293 cells gave negative
staining results (not shown). In cultured microglia >92% of the cells were found
positive for CD11b confirming the identity of these cells (fig. 4-1C). Parallel stain-
ings for CXCR3 resulted in more than 95% CXCR3 positive cells (fig. 4-1D).
Control experiments with an isotype-matched (IgG1) antibody against GFAP
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Figure 4-1 CXCR3 protein expression in CXCR3 transfected HEK293 cells and cultured human microglial
cells.
HEK293 cells transfected with human or mouse CXCR3 revealed positive staining (A and B respectively).
CD11b staining in more than 92% of the cells identified them as microglia (C). A pronounced CXCR3 sig-
nal was detected in human microglia (D). Control experiments with an iso-type matched antibody against
GFAP or without primary antibodies yielded no signal (not shown). Scale bars = 50 µm.
(Chemicon), or without primary antibodies did not show staining (data not shown).
As already shown for CXCR3 and other chemokine receptors in glial cells,
immunostaining for CXCR3 was predominantly located in the cytoplasm with
minor staining of the membrane 2,12,25. 
Using RT-PCR experiments we were not able to detect expression of CCR7 in
both microglia and CXCR3 transfected HEK293 cells (fig. 4-2). As a positive con-
trol to the two different sets of primers, lymph node tissue was used where pro-
nounced expression of CCR7 mRNA was found (fig. 4-2). In a recent publication
we already demonstrated CXCR3 mRNA expression in human microglia cells by
means of RT-PCR 2 which was further confirmed by in situ hybridization analysis.
CXCR3 transfected HEK293 served as a positive control for the used probe.
Pronounced CXCR3 mRNA expression was detected in transfected HEK293 (fig.
4-2C), whereas the sense control appeared was negative (fig. 4-2C inset). In human
cultured microglia CXCR3 mRNA expression was found in the small rim of cyto-
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Figure 4-2 CCR7 and CXCR3 mRNA expression in human microglia and HEK293 cells.
CCR7 expression in human microglia (mic) and HEK293 cells (HEK) was investigated by RT-PCR (A). Two
different primer sets (a and b) for CCR7 were used, resulting in a product of 977 or 355 basepairs (bp),
respectively. No CCR7 mRNA expression was observed in human microglia or HEK293 cells whereas lymph
node (LN) tissue showed bands of the expected size.The quality of all cDNAs was verified by using GAPDH
primers in parallel experiments. nc: negative control, MM: molecular weight marker, the highlighted band is
500 bp. In situ hybridization revealed the expression of CXCR3 mRNA in human microglia (see arrowheads
for the dark hybridization signal) (B) and hCXCR3 transfected HEK293 cells (C). Hybridization with sense
probes did not yield a signal (C, inset). Scale bars = 10 µm
plasm around the nucleus (fig. 4-2B) (see arrowheads), a signal that was absent with
the sense probe (fig. 4-2C inset). 
Effects of hCCL21 and other ligands for CXCR3 on chemotaxis of
human microglia
The functional activity of CXCR3 in murine microglia in response to CXCL9, 10
and CCL21 was demonstrated recently 2,3,24. Similar as murine microglia, human
microglia migrated in response to hCCL21 in a concentration-dependent manner
(fig. 4-3A). The maximum migratory response was found, between 0.1 and 1 nM,
which was comparable with migratory responses for CXCL9 or CXCL10 (fig. 
4-3A) 2. Moreover, CCL21-induced chemotaxis was sensitive to pertussis toxin,
indicating the involvement of Gαi-coupled chemokine receptors (fig. 4-3A). Again,
similar to our findings in murine microglia, hCCL19 had no effect in human
microglia (fig. 4-3A). 
Using CXCR3 deficient mice it was demonstrated that mCXCR3 is the responsi-
ble chemokine receptor for murine CCL21 in microglia 24. To further address this
also in human microglia we first tried to block CXCR3 signaling by antibody treat-
ment. However, our hCXCR3 antibody did not influence the migration of
hCXCR3 transfected HEK203 cells in response to CXCL9 and 10 (data not shown)
and was therefore not suitable. Next, a desensitization approach was performed since
we have shown previously that CCL21 and CXCL10 cross-desensitize their signal-
ing in mice, indicating that both ligands activate the same receptor 3. It is shown
here that the effect of CCL21 was absent in microglia in the presence of 10 nM
CXCL10 (fig. 4-3B), whereas the chemotactic activity of another chemokine,
CX3CL1, was not affected (fig. 4-3B). These results strongly suggests that CXCR3
is desensitized by the presence of 10 nM CXCL10 and the lack of a CCL21 response
indicate that CXCR3 is the responsible chemokine receptor for CCL21 in human
microglia. 
hCCL21 does not activate hCXCR3 in HEK293 cells
HEK293 cells were transfected with murine or human CXCR3 and investigated for
possible responses to CCL21 and other CXCR3 ligands. In agreement with previ-
ously published findings, it was found that HEK293 cells transfected with
mCXCR3 responded to CCL21 and CXCL9 in a concentration-dependent manner
(fig. 4-3C). HEK293 cells transfected with hCXCR3 migrated when exposed to
CXCL9 or CXCL10, but no migratory response was observed to CCL21 (fig. 
4-3D) 14,28. Migration of mock transfected HEK293 was never observed (data not
shown). 
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Figure 4-3 Effects of CXCR3 ligands on the migratory behavior of human microglia and CXCR3 trans-
fected HEK293 cells.
(A) Concentration-dependent chemotaxis of human microglia in response to CCL21, pretreatment with
PTX inhibited the migratory response to CCL21. No typical concentration-dependent migration was
observed in response to the CCR7 ligand CCL19. The maximum migratory response observed with CCL21
was comparable to those for other CXCR3 ligands CXCL9 and CXCL10. (B) The migratory response of 
1 nM CCL21 was significantly inhibited by the presence of 10 nM CXCL10. No effect of 10 nM CXCL10
was found on the migratory response of 1nM CX3CL1. (C) HEK293 cells transfected with mCXCR3 migrat-
ed towards both CXCL9, CXCL10 (data not shown) and CCL21 in a dose dependent manner. (D) hCXCR3
transfected HEK293 cells showed chemotaxis in response to CXCL9 and CXCL10 (data not shown) but
not to CCL21. The graphs provide the results from a typical experiment, similar results were obtained in
at least 3 independent experiments. Data are given in mean ± SEM, for experiments with human microglia:
n=4 and with transfected HEK293: n=6. Asterisks indicate significantly different from control (p ≤ 0.05).
Discussion
In a recent publication we already demonstrated the presence and functional activi-
ty of CXCR3 in murine microglia cells in response to CXCL9,10 but also CCL21.
Although hCXCR3 in recombinant expression systems is not activated by hCCL21,
we investigated wether primary human microglia respond to CCL21 via CXCR3.
In this study we have clearly demonstrated that human microglia express CXCR3,
confirming our previous results. Moreover, we have shown that microglia respond
to all CXCR3 ligands tested, including CCL21. To provide unambiguous evidence
for CXCR3-CCL21 mediated chemotaxis, a cross-desensitization experiment was
performed during which CXCL10 significantly diminished CCL21 induced 
migration.  
Signaling of hCXCR3 is different in microglia
Pharmacological differences of chemokine receptors expressed in different expres-
sion systems have already been published (see CCR5 signaling in various cells;
5,20,21). Our results suggest that the pharmacology of hCXCR3 depends on it cel-
lular background. Since we did not detect a microglia specific splice variant for
CXCR3 in mouse and humans (data not shown), other mechanisms must account
for the here presented difference. Post-translational modifications (i.e. palmitoyla-
tion), which may influence signaling cascades are known for chemokine receptors
6,23. Moreover, interactions with regulator of G protein signaling (RGS) protein may
influence chemokine receptor functioning 17. Additionally, we observed expression
of another CCL21-binding chemokine receptor-like protein called CCX-CKR in
human and murine microglia (results not shown). Expression of CCX-CKR in var-
ious cell lines alone has never been demonstrated to exert any functional activity and
has therefore been disqualified as an official chemokine receptor 11,18,30. Since,
chemokine receptors can form heterodimers that regulate their functional activity,
co-expression of CCX-CKR in microglia might be another possible explanation for
CXCR3 mediated CCL21 response in human microglia 26.
hCCL21 might be important in human brain inflammation
Hence, the mechanism accounting for the effects of hCCL21 in human microglia
requires further investigation. However, the presented results show that hCCL21
induces functional responses in human microglia similar to those in murine cells.
This shows for the first time functional activity of hCXCR3 in response to hCCL21.
Since hCCL21 expression was recently detected in CSF of patients with neurode-
generative diseases 22, it is suggested that hCCL21 is involved in neuro-immune sig-
naling also in humans. 
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